Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PROCEPT BioRobotics (PRCT) Shares Outstanding (2020 - 2025)

PROCEPT BioRobotics has reported Shares Outstanding over the past 6 years, most recently at $56.3 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $56.3 million for Q4 2025, up 2.93% from a year ago — trailing twelve months through Dec 2025 was $56.3 million (up 2.93% YoY), and the annual figure for FY2025 was $56.3 million, up 2.93%.
  • Shares Outstanding for Q4 2025 was $56.3 million at PROCEPT BioRobotics, up from $55.9 million in the prior quarter.
  • Over the last five years, Shares Outstanding for PRCT hit a ceiling of $56.3 million in Q4 2025 and a floor of $5.2 million in Q1 2021.
  • Median Shares Outstanding over the past 5 years was $47.9 million (2023), compared with a mean of $45.1 million.
  • Biggest five-year swings in Shares Outstanding: skyrocketed 840.95% in 2021 and later grew 1.65% in 2023.
  • PROCEPT BioRobotics' Shares Outstanding stood at $43.7 million in 2021, then grew by 2.64% to $44.8 million in 2022, then increased by 13.26% to $50.8 million in 2023, then rose by 7.77% to $54.7 million in 2024, then rose by 2.93% to $56.3 million in 2025.
  • The last three reported values for Shares Outstanding were $56.3 million (Q4 2025), $55.9 million (Q3 2025), and $55.6 million (Q2 2025) per Business Quant data.